4.1 Article

Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion

Journal

PEDIATRIC EMERGENCY CARE
Volume 24, Issue 9, Pages 615-617

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PEC.0b013e3181850c91

Keywords

Ecstasy; methylenedioxymethamphetamine; MDMA; SIADH; hyponatremia; intoxication

Ask authors/readers for more resources

3,4-Methylenedioxymethamphetamine (MDMA), popularly known as the illicit drug Ecstasy, is an amphetamine derivative that has become widely abused throughout the United States and other industrialized nations. 3,4-Methylenedioxymethamphetamine has an undeserved reputation as a safe drug among its users, but MDMA shares the toxicity profile of other amphetamines. Its use may result in lethal cardiovascular, hepatic, metabolic, or neurological toxicity. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a unique toxicity that may occur after isolated MDMA use. Although the phenomenon is well described in adults, reports of MDMA-induced SIADH and symptomatic hyponatremia in children are rare. We describe a 13-year-old girl who experienced MDMA-induced SIADH with symptomatic hyponatremia. Toxicity of MDMA, in particular, the pathophysiology and treatment of MDMA-induced hyponatremia, is discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available